Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00247156 · ClinicalTrials.gov registry record · Phase 1
An Autism Study Using Nambudripad's Food Allergy Elimination Treatments
A Phase 1 study of Autism and Food Allergies, sponsored by Nambudripad's Allergy Research Foundation.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT00247156: Completed Phase 1 study of Autism and Food Allergies, sponsored by Nambudripad's Allergy Research Foundation.
NCT00247156 is a Phase 1 study of Autism and Food Allergies that has completed, run by Nambudripad's Allergy Research Foundation. The registered enrollment target is 60 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00247156, a Phase 1 study of Autism and Food Allergies, has completed, sponsored by Nambudripad's Allergy Research Foundation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
1\. We hypothesize that children in the experimental group will show a significant improvement over the control group as all food allergens groups and some other relevant allergenic substances are desensitized in a systematic way using the NAET® methodology within the specified period of study.
Conditions Studied
Interventions
- PROCEDURE Acupressure treatments and NAET treatments
Study Locations (1)
California
- PNIB Research Center - Buena Park
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2004-11 |
| Est. Completion | 2005-11 |
| Phase | Phase 1 |
What the finished NCT00247156 record still lists
NCT00247156 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 183-participant average among 104 other Autism trials with a reported enrollment target (67% lower).
The record links to 2 conditions, with Autism appearing as the primary indexed condition, and to 1 intervention - of which Acupressure treatments and NAET treatments is the first listed.
NCT00247156 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00247156 about?
NCT00247156 is a clinical study titled "An Autism Study Using Nambudripad's Food Allergy Elimination Treatments". 1\. We hypothesize that children in the experimental group will show a significant improvement over the control group as all food allergens groups and some other relevant allergenic substances are desensitized in a systematic way using the NAET® methodology within the specified period of study.
What is the current status of trial NCT00247156?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2004-11. Estimated completion is 2005-11.
What conditions does trial NCT00247156 study?
This clinical trial studies the following conditions: Autism, Food Allergies.
What interventions are being tested in trial NCT00247156?
The interventions under investigation include: Acupressure treatments and NAET treatments (PROCEDURE).
Who is sponsoring clinical trial NCT00247156?
This trial is sponsored by Nambudripad's Allergy Research Foundation, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00247156 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00247156's enrollment target sits among peer trials
60 53rd of 104 higher than 51 of 104 other Autism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Adia MED of Winter Park LLC Autism Spectrum Disorder Research Study
RECRUITING · Phase 1
-
Trichuris Suis Ova in Autism Spectrum Disorders
COMPLETED · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Modified Pivotal Response Treatment for Insistence on Sameness in Autistic Youth
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia